癌症相关血栓的结果的差异取决于癌症类型的不同
Ramón Lecumberri1, María Marcos-Jubilar1, José Hermida1
1Hematology Service, Cancer Center Universidad de Navarra, Pamplona, Spain.
Thrombosis and haemostasis
|February 10, 2025
概括
癌症患者面临来自静脉血栓塞栓症 (VTE) 的更糟糕的结果,根据癌症类型,复发和出血的风险各不相同. 平衡这些风险是定制癌症相关血栓瘤 (CAT) 治疗和改善患者存活率的关键.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 临床医学 临床医学
背景情况:
- 与非癌症患者相比,癌症患者的静脉血栓塞栓症 (VTE) 结果较差.
- 癌症相关血栓形成 (CAT) 带来了独特的挑战,包括更高的复发风险,出血和死亡率.
- 在抗凝血治疗期间,静脉瘤复发和大出血 (MB) 风险之间的平衡因癌症类型而异.
研究的目的:
- 审查已公布的关于CAT的癌症类型特异性结果的数据.
- 在不同类型的癌症中分析VTE复发与MB的风险.
- 为个人化治疗策略和CAT的未来临床试验设计提供信息.
主要方法:
- 对最近随机临床试验数据的系统审查.
- 来自大型注册表报告分离的CAT数据的癌症类型的结果分析.
- 在各种癌症诊断中对复发率和MB事件率的比较评估.
主要成果:
- 在不同类型的癌症中,CAT风险概况存在显著的异质性.
- 在某些癌症中,复发风险占主导地位;在其他癌症中,在抗凝时,MB风险更高.
- 数据表明需要基于个体癌症诊断的量身定制的管理方法.
结论:
- 通过平衡复发和MB风险,个性化CAT管理对于改善患者的治疗结果至关重要.
- 了解癌症类型特定的风险可以指导抗凝治疗的临床决策.
- 这种风险益处评估对于优化当前治疗方法和设计未来在CAT中的临床试验至关重要.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
204
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
相关概念视频
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Cancer
47.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.5K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
